LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
Revenue
LeMaitre Vascular Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Revenue
$193.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
LeMaitre Vascular Inc
Revenue Breakdown
Breakdown by Geography
LeMaitre Vascular Inc
Total Revenue:
193.5m
USD
|
Americas:
130.3m
USD
|
EMEA:
51.1m
USD
|
Asia Pacific:
12.1m
USD
|
Breakdown by Segments
LeMaitre Vascular Inc
See Also
What is LeMaitre Vascular Inc's Revenue?
Revenue
193.5m
USD
Based on the financial report for Dec 31, 2023, LeMaitre Vascular Inc's Revenue amounts to 193.5m USD.
What is LeMaitre Vascular Inc's Revenue growth rate?
Revenue CAGR 10Y
12%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for LeMaitre Vascular Inc have been 14% over the past three years , 13% over the past five years , and 12% over the past ten years .